Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Eron

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of the International AIDS Society|December 15, 2021
Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES projectAnne Drapkin Lyerly, Richard Beigi, Linda-Gail Bekker, et al.
American Journal of Epidemiology|August 5, 2011
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north americaAlison G Abraham, Bryan Lau, Steven Deeks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysisAmy C Justice, Sharada P Modur, Janet P Tate, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
Journal of Virology|October 10, 2008
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremiaGeorgia D Tomaras, Nicole L Yates, Pinghuang Liu, et al.
HIV Medicine|March 28, 2022
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohortBrandon Luu, Stephanie Ruderman, Robin Nance, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of the International AIDS Society|December 15, 2021
Ending the evidence gap for pregnancy, HIV and co-infections: ethics guidance from the PHASES projectAnne Drapkin Lyerly, Richard Beigi, Linda-Gail Bekker, et al.
American Journal of Epidemiology|August 5, 2011
Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north americaAlison G Abraham, Bryan Lau, Steven Deeks, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysisAmy C Justice, Sharada P Modur, Janet P Tate, et al.
Plos One|March 8, 2014
Comparison of illumina and 454 deep sequencing in participants failing raltegravir-based antiretroviral therapyJonathan Z Li, Brad Chapman, Patrick Charlebois, et al.
Journal of Virology|October 10, 2008
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremiaGeorgia D Tomaras, Nicole L Yates, Pinghuang Liu, et al.
HIV Medicine|March 28, 2022
Tobacco smoking and binge alcohol use are associated with incident venous thromboembolism in an HIV cohortBrandon Luu, Stephanie Ruderman, Robin Nance, et al.
The Lancet. Infectious Diseases|March 8, 2014
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trialBeatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, et al.
The New England Journal of Medicine|July 20, 2011
Prevention of HIV-1 infection with early antiretroviral therapyMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The New England Journal of Medicine|July 19, 2016
Antiretroviral Therapy for the Prevention of HIV-1 TransmissionMyron S Cohen, Ying Q Chen, Marybeth McCauley, et al.
The Lancet. HIV|January 27, 2019
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studiesKeri N Althoff, Kelly A Gebo, Richard D Moore, et al.
Pageof 7